// STATE LEGISLATION TRACKER

Arkansas SB 29: TO MAKE TRAFFICKING FENTANYL A CAPITAL OFFENSE; CONCERNING CAPITAL OFFENSES; AND CONCERNING FENTANYL OFFENSES.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Arkansas
Bill: SB 29
Filed: 2020-12-31
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Arkansas SB29 was a criminal sentencing bill focused on fentanyl trafficking, not peptide prescribing, compounding, telehealth, or clinician scope. Based on the title, subjects, and available status, it has no direct impact on compounded peptides or peptide patients.

Key Points

No apparent change to compounded peptide access
No apparent change to off-label prescribing
No apparent change to telehealth prescribing rules
No apparent change to NP or naturopathic scope
Targets fentanyl trafficking, not therapeutic peptides

What to Watch For

Note This is a controlled-substance criminal bill, so it matters only if a product or conduct involves fentanyl.

Note No visible link to FDA 503A or 503B compounding rules from the provided bill information.

Note No visible change to prescription monitoring, telehealth, or peptide clinic operations.

Where the Bill Stands

The bill was in the Senate during the 2021 session and ended with sine die adjournment, so it did not become law.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws